Clinical trial
A Randomized, Double-Blind, Vehicle-Controlled Ascending Multiple Dose and Clinical Proof-Of-Concept Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VTP-38543 in Adult Patients With Mild to Moderate Atopic Dermatitis
NCT02655679 is registered in ClinicalTrials.gov with Vitae Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Vehicle-Controlled Ascending Multiple Dose and Clinical Proof-Of-Concept Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VTP-38543 in Adult Patients With Mild to Moderate Atopic Dermatitis
- Lead sponsor
- Vitae Pharmaceuticals, Inc.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 15, 2015
- Completion date
- September 9, 2016
- Enrollment
- 104 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.